For pharmacists, from Drug Topics: News, features, and analysis of legislative matters of interest to pharmacists
November 3, 2009
By:Bruce T. Roberts, RPh
In the prescription drug market, discriminatory pricing is common for independent community pharmacies and their patients. This fall, a Federal District Court in New York will consider a critical case: Drug Mart Pharmacy Corp. et a. v. American Home Products Corp. et al. The outcome of the case may determine whether discriminatory pricing techniques are illegal.
 |
November 3, 2009
By:Drug Topics staff
With the subject of healthcare reform on the front burner in Washington and across the country, Drug Topics invited members of its Frontline editorial advisory board to share their thoughts. A selection of their responses is presented here.
|
October 8, 2009
By:Martin Sipkoff
When manufacture of biogenerics is a legal reality, brand manufacturers will still retain a strong market share for several years.
|
October 8, 2009
By:Ned Milenkovich, PharmD, JD
The FDA can require risk evaluation and mitigation strategies for certain prescription drugs and biological products, to ensure that the benefits of such products outweigh the risks. The effect of REMS ripples down through the supply chain to affect how pharmacies dispense medication.
|
October 8, 2009
By:Fred Gebhart, Contributing Editor
Hospitals and health systems have taken the lead in expanding the role of pharmacy technicians. "The better educated techs are, the more they can support pharmacists," says Mary Mohr, RPh, MS, of Clarian Health.
|
October 1, 2009
By:Alaina Scott, Senior Editor
Pharmacy groups have filed three lawsuits that argue that California, New York, and Washington have not met their legal requirements to assure Medicaid patients receive access and quality care at least equal to patients in the general public.
|
September 22, 2009
By:Alaina Scott, Senior Editor
A coalition of healthcare industry groups has sent a letter to the bipartisan leadership in Congress seeking to delay pending Medicaid cuts.
|
September 18, 2009
By:Fred Gebhart, Contributing Editor
The Joint Commission is targeting patient safety failures with a new program that will directly affect pharmacy operations.
|
September 9, 2009
By:Alaina Scott, Senior Editor
GlaxoSmithKline has announced that the FDA's Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of Cervarix, the company's candidate cervical cancer vaccine.
|
| 
| Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
|
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION|
 | | | |
| Is knowledge of herbal supplements valuable to you in the practice of pharmacy? | | | No, not at all. | | 0% | | | Yes, somewhat. | | 30% | | | Definitely helpful. | | 52% | | | It comes up daily. | | 17% | |
| | | |
|
|
  Drug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.
Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.  | 
